Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosynthetic (recombinant) α-2-interferonJACOBS, A. D; NAIEM, F; CHAMPLIN, R. E et al.Blut. 1985, Vol 50, Num 1, pp 33-34, issn 0006-5242Article

Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferonMARCELLIN, P; COLIN, J.-F; BOYER, N et al.Lancet (British edition). 1991, Vol 338, Num 8770, issn 0140-6736, p. 828Article

Treatment of multiple myeloma with recombinant α-interferonQUESADA, J. R; ALEXANIAN, R; HAWKINS, M et al.Blood. 1986, Vol 67, Num 2, pp 275-278, issn 0006-4971Article

Mechanisms of interferon-alpha induced apoptosis in malignant cellsTHYRELL, Lena; ERICKSON, Sven; ZHIVOTOVSKY, Boris et al.Oncogene (Basingstoke). 2002, Vol 21, Num 8, pp 1251-1262, issn 0950-9232Article

Alpha interferon treatment of patients with hairy-cell leukaemiaHAGBERG, H; ALM, G; BJORKHOLM, M et al.Scandinavian journal of haematology. 1985, Vol 35, Num 1, pp 66-70, issn 0036-553XArticle

Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatographyMECS, I; CHIN, D; FOX, F et al.Archives of virology. 1984, Vol 81, Num 3-4, pp 303-311, issn 0304-8608Article

Association of IRF5 polymorphisms with activation of the interferon α pathwayRULLO, Ornella J; WOO, Jennifer M. P; HUI WU et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 3, pp 611-617, issn 0003-4967, 7 p.Article

Activated Ras/MEK Inhibits the Antiviral Response of Alpha Interferon by Reducing STAT2 LevelsCHRISTIAN, Sherri L; COLLIER, Thaddeus W; DONG ZU et al.Journal of virology. 2009, Vol 83, Num 13, pp 6717-6726, issn 0022-538X, 10 p.Article

Interferon α decreases expression of human scavenger receptor class Bl, a possible HCV receptor in hepatocytesMURAO, K; IMACHI, H; YU, X et al.Gut. 2008, Vol 57, Num 5, pp 664-671, issn 0017-5749, 8 p.Article

Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon productionSCHMIDT, Barbara; ASHLOCK, Brittany; NEIPEL, Frank et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 9, pp 4300-4302, issn 0095-1137, 3 p.Article

Interferon-α: Regulatory effects on cell cycle and angiogenesisROSEWICZ, Stefan; DETJEN, Katharina; SCHOLZ, Arne et al.Neuroendocrinology (Basel). 2004, Vol 80, pp 85-93, issn 0028-3835, 9 p., SUP1Conference Paper

Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alphaKONTSEK, P; BORECKY, L; LACKOVIC, V et al.Acta virologica (English ed.). 1989, Vol 33, Num 3, pp 254-261, issn 0001-723XArticle

Response of differentiated but not anaplastic teratoma to interferonRUSTIN, G. J. S; KAYE, S. B; WILLIAMS, C. J et al.British journal of cancer. 1984, Vol 50, Num 5, pp 611-616, issn 0007-0920Article

Immunolocalisation of α interferon in liver diseaseSUTHERLAND, C. G. G; AL-BADRI, A. M. T; HOWATSON, A. G et al.Journal of clinical pathology. 1989, Vol 42, Num 10, pp 1065-1069, issn 0021-9746, 5 p.Article

Recombinant alpha-2 interferon in the treatment of hairy cell leukemiaTHOMPSON, J. A; BRADY, J; KIDD, P et al.Cancer treatment reports. 1985, Vol 69, Num 7-8, pp 791-793, issn 0361-5960Article

Cloning of a bovine interferon-α gene subfamily and comparisons between genetically engineered and leukocyte bovine interferonsVELAN, B; COHEN, S; GROSFELD, H et al.Developments in biological standardization. 1985, Vol 60, pp 355-369, issn 0301-5149Article

Essai phase I' de tolérance à des doses croissantes d'interféron recombinant humain α2 chez des patients porteurs de cancers avancés = Phase I study of tolerance to increasing doses of recombinant DNA human alpha-2 interferon in patient with advanced malignant tumorsBRETAUDEAU, B; PALANGIE, T; SCHWAB, D et al.Bulletin du cancer. 1984, Vol 71, Num 1, pp 40-49, issn 0007-4551Article

Distribution of interferon-α₂ genes in humansLIAO, M. J; LEE, N; DIPAOLA, M et al.Journal of interferon research. 1994, Vol 14, Num 4, pp 183-185, issn 0197-8357Conference Paper

Monoclonal anti-idiotypic antibodies imitating biological effect of human alpha interferonsNAGIEVA, F. G; BARKOVA, E. P; NIKULINA, V. G et al.Voprosy virusologii. 1991, Vol 36, Num 5, pp 402-406, issn 0507-4088Article

Les médicaments antiviraux = Antiviral agentsHELFER, C; WALDVOGEL, F.Médecine et hygiène. 1987, Vol 45, Num 1693, pp 736-741, issn 0025-6749, 4 p.Article

Interferon-α : A key factor in autoimmune disease?PLSKOVA, Jarka; GREINER, Kathrin; MUCKERSIE, Elizabeth et al.Investigative ophthalmology & visual science. 2006, Vol 47, Num 9, pp 3946-3950, issn 0146-0404, 5 p.Article

Modulation of cell proliferation by human recombinant interleukin-1 and immune interferonTSAI, S.-C. J; GAFFNEY, E. V.Journal of the National Cancer Institute. 1987, Vol 79, Num 1, pp 77-81, issn 0027-8874Article

Psoriasis and alpha-interferonQUESADA, J. R; GUTTERMAN, J. U.Lancet (British edition). 1986, Num 8496, pp 1466-1468, issn 0140-6736Article

Measurement of 2', 5'-oligoadenylate synthetase in patients receiving interferon-alphaMERRITT, J. A; BORDEN, E. C; BALL, L. A et al.Journal of interferon research. 1985, Vol 5, Num 1, pp 191-198, issn 0197-8357Article

Systemic alpha-interferon therapy of multiple sclerosisKNOBLER, R. L; PANITCH, H. S; OLDSTONE, M. B. A et al.Neurology. 1984, Vol 34, Num 10, pp 1273-1279, issn 0028-3878Article